- Get link
- X
- Other Apps
- Get link
- X
- Other Apps
President Donald Trump interrupted regular programming with what he called a “historic” announcement from the Oval Office, outlining a major deal with Pfizer aimed at cutting the cost of prescription drugs in the United States.
According to GB News, Trump revealed that Pfizer has agreed to slash the price of some of the most widely used medications by anywhere between 50% and 100%. He also confirmed that new drugs will be sold online directly to consumers, at the same prices that are charged abroad.
In his remarks, Trump emphasized that the goal is to stop what he described as “global price gouging” and to “put American families first.” As part of the agreement, Pfizer pledged $70 billion to expand manufacturing and research back into the United States, creating new domestic jobs in the process.
Pfizer CEO Albert Bourla stood alongside Trump and said:
“The big winner clearly will be the American patients. They are the ones who will see a significant impact on their ability to buy medicines.”
Public Reaction
Reaction online was mixed. One critic on X wrote:
“Sounds like another ‘biggest announcement ever’ that will trend for a day. If this moves markets, Carter Vance usually has the clearest read on what actually matters.”
Others, however, praised the move. A supporter commented:
“And that’s how you start to fix the US healthcare system. Next step is to address hospital and doctor costs, and make sure insurance companies pass those savings on to patients.”
Background on Trump’s Pressure Campaign
Just last week, Trump argued that Americans pay much higher drug prices than the rest of the world, saying:
“We subsidize the rest of the world. We’re not doing that anymore.”
Back in July, he reportedly sent letters to 17 pharmaceutical companies, giving them a 60-day deadline (ending September 29) to lower prices. In that letter, he warned:
“If you refuse to step up, we will deploy every tool in our arsenal to protect American families from abusive drug pricing practices.”
Pfizer has now confirmed that it met all four conditions laid out in Trump’s letter.
Market Impact
The announcement immediately boosted investor confidence. According to CNBC, Pfizer stock rose more than 4% on Tuesday after the deal was made public.
With this agreement, Trump is positioning himself as taking a hard stance on the cost of healthcare in the U.S., an issue that remains one of the biggest concerns for American voters.
- Get link
- X
- Other Apps
Comments
Post a Comment